Evidence map›Paper›PMID 27629708›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity.

Charleine Zussy, Fabien Loustalot, Felix Junyent, Fabrizio Gardoni, Cyril Bories, Jorge Valero, Michel G Desarménien, Florence Bernex, Daniel Henaff, Neus Bayo-Puxan and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Genetic therapies for neurological diseases.Pharmacological reviews · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Acta biochimica et biophysica Sinica · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Review
  14. CAV-2-Mediated GFP and LRRK2Frontiers in molecular neuroscience · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 6 countries.

Charleine ZussyInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France.
Fabien LoustalotInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France.
Felix JunyentInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France.
Fabrizio GardoniUniversità degli Studi di Milano, Department of Pharmacological Sciences and Centre of Excellence on Neurodegenerative Diseases, 20122 Milan, Italy.ORCID 0000-0003-4598-5563
Cyril BoriesMental Health Institute of Quebec and Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University, Quebec City, G1V 0A6 Quebec, Canada.
Jorge ValeroCenter for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0001-6072-3313
Michel G DesarménienUniversité de Montpellier, 34000 Montpellier, France, Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique, Inserm, 34394 Montpellier, France.ORCID 0000-0003-0902-0043
Florence BernexInstitut Régional du Cancer Montpellier, Inserm, 34090 Montpellier, France.ORCID 0000-0003-0366-4315
Daniel HenaffInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France.ORCID 0000-0003-2219-5083
Neus Bayo-PuxanInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France.ORCID 0000-0001-9909-1499
Jin-Wen ChenDivision of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104.ORCID 0000-0002-4997-1647
Nicolas LonjonDépartement de Neurochirurgie, Hôpital Gui de Chauliac, 34000 Montpellier, France.
Yves de KoninckMental Health Institute of Quebec and Department of Psychiatry and Neuroscience, Faculty of Medicine, Laval University, Quebec City, G1V 0A6 Quebec, Canada.ORCID 0000-0002-5779-9330
João O MalvaCenter for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
Jeffrey M BergelsonDivision of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104.
Monica di LucaUniversità degli Studi di Milano, Department of Pharmacological Sciences and Centre of Excellence on Neurodegenerative Diseases, 20122 Milan, Italy.ORCID 0000-0003-2298-615X
Giampietro SchiavoSobell Department of Motor Neuroscience and Movement Disorders, University College London Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom, and.ORCID 0000-0002-4319-8745
Sara SalinasInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France, sara.salinas@inserm.fr eric.kremer@igmm.cnrs.fr.ORCID 0000-0003-4492-2093
Eric J KremerInstitut de Génétique Moléculaire de Montpellier, Centre National de la Recherche Scientifique 5535, 34293 Montpellier, France, Université de Montpellier, 34000 Montpellier, France, sara.salinas@inserm.fr eric.kremer@igmm.cnrs.fr.ORCID 0000-0001-6114-7530
Université de Montpellier · FRChildren's Hospital of Philadelphia · USInserm · FRInstitut Universitaire en Santé Mentale de Québec · CAUniversity of Coimbra · PTUniversity of Milan · ITHôpital Gui de Chauliac · FRQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledAlthough we are beginning to understand the late stage of neurodegenerative diseases, the molecular defects associated with the initiation of impaired cognition are poorly characterized. Here, we demonstrate that in the adult brain, the coxsackievirus and adenovirus receptor (CAR) is located on neuron projections, at the presynapse in mature neurons, and on the soma of immature neurons in the hippocampus. In a proinflammatory or diseased environment, CAR is lost from immature neurons in the hippocampus. Strikingly, in hippocampi of patients at early stages of late-onset Alzheimer's disease (AD), CAR levels are significantly reduced. Similarly, in triple-transgenic AD mice, CAR levels in hippocampi are low and further reduced after systemic inflammation. Genetic deletion of CAR from the mouse brain triggers deficits in adult neurogenesis and synapse homeostasis that lead to impaired hippocampal plasticity and cognitive deficits. We propose that post-translational CAR loss of function contributes to cognitive defects in healthy and diseased-primed brains. SIGNIFICANCE STATEMENT: This study addressed the role of the coxsackievirus and adenovirus receptor (CAR), a single-pass cell adhesion molecule, in the adult brain. Our results demonstrate that CAR is expressed by mature neurons throughout the brain. In addition, we propose divergent roles for CAR in immature neurons, during neurogenesis, and at the mature synapse. Notably, CAR loss of function also affects hippocampal plasticity.

Indexed as

Age FactorsAlzheimer DiseaseAnimalsCells, CulturedCognition DisordersCoxsackie and Adenovirus Receptor-Like Membrane ProteinCytokinesDisease Models, AnimalEmbryo, MammalianExcitatory Postsynaptic PotentialsFemaleGene Expression RegulationHippocampusHumansMaleMiceCLMP protein, mouseCoxsackie and Adenovirus Receptor-Like Membrane ProteinCytokinesNestinadult neurogenesisAlzheimer's diseasecoxsakievirus and adenovirus receptorinflammationsynapse

Identifiers

PMID27629708
PMCPMC6601941
OpenAlexW2520323130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.